According to the UnivDatos, the high prevalence of Alzheimer's disease, an aging population, and substantial governmental and private funding will drive the scenario of the global Alzheimer’s Drugs and as per their “Alzheimer’s Drugs Market” report, the Market was valued at USD ~4.85 billion in 2023, growing at a CAGR of ~11% during the forecast period from 2024 - 2032...